doi:10.1176/appi.ajp.163.9.1648-b

Correction for Valenstein et al., Am J Psychiatry 163 (7) 1219-1225.
Am J Psychiatry 163:1648-b, September 2006
doi: 10.1176/appi.ajp.163.9.1648-b
© 2006 American Psychiatric Association



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via Google Scholar



	Search for Related Content

In the article "What Happened to Lithium? Antidepressant Augmentationin Clinical Settings" (Am J Psychiatry 2006; 163:1219–1225),Table 1 (p.1221) contained errors in the presentation and prevalencesof antidepressant-antidepressant augmentation strategies. Arevised table with an alternate title to more clearly reflectthe denominators used for calculating percentages appears below.

View this table:
[in this window]
[in a new window]

TABLE 1

Also, in the third paragraph of the Results section, the secondand third sentences should read as follows: "Bupropion and sertralinewere the most frequently appearing antidepressants in combinedantidepressant augmentation strategies. Bupropion appeared in10,279 (38%) of all antidepressant-antidepressant combinationsand sertraline appeared in 6,727 (25%)."

This Article

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a Colleague

Similar articles in this journal

Alert me to new issues of the journal

Add to My Articles & Searches

Download to citation manager

Citing Articles

Citing Articles via Google Scholar

Search for Related Content

Get information about faster international access.